P01
|
Retinal Neuroaxonal loss and Disease Progression in Multiple Sclerosis
Poster flash presentation & ePoster
Neuroinflammatory / -infectious diseases
F. Burguet Villena
Speaker
1. Department of Neurology, University Hospital Basel, Basel, Switzerland; 2. Department of Clinical Research, University Hospital and University of Basel, Basel, Switzerland; 3. Research Center for Clinical Neuroimmunology and Neuroscience Basel (RC2NB)L. Hofer Department of Clinical Research, University Hospital and University of Basel, Basel, Switzerland N. Cerdá Fuertes 1. Department of Neurology, University Hospital Basel, Basel, Switzerland; 2. De-partment of Clinical Research, University Hospital and University of Basel, Basel, Switzerland; 3. Research Center for Clinical Neuroimmunology and Neuroscience Basel (RC2NB)S. Sellathurai 1. Department of Clinical Research, University Hospital and University of Basel, Ba-sel, Switzerland; 2. Research Center for Clinical Neuroimmunology and Neuroscience Basel (RC2NB), 3. Translational Imaging in Neurology (ThINK) Basel, Department of BiomedK. Schoenholzer 1. Department of Neurology, University Hospital Basel, Basel, Switzerland; 2. De-partment of Clinical Research, University Hospital and University of Basel, Basel, Switzerland; 3. Research Center for Clinical Neuroimmunology and Neuroscience Basel (RC2NB)M. D'Souza 1. Department of Neurology, University Hospital Basel, Basel, Switzerland. 2. 3. Research Center for Clinical Neuroimmunology and Neuroscience Basel (RC2NB), University Hospital and University of Basel, Basel, Switzerland.J. Oechtering 1. Department of Neurology, University Hospital Basel, Basel, Switzerland. 2. Department of Clinical Research, University Hospital and University of Basel, Basel, Switzerland 3. Research Center for Clinical Neuroimmunology and Neuroscience Basel (RC2NB),L. Kappos 1. Department of Clinical Research, University Hospital and University of Basel, Basel, Switzerland , 2. Research Center for Clinical Neuroimmunology and Neuroscience Basel (RC2NB), University Hospital and University of Basel, Basel, Switzerland.C. Granziera 1. Department of Neurology, University Hospital Basel, Basel, Switzerland. 2. Department of Clinical Research, University Hospital and University of Basel, Basel, Switzerland 3. Research Center for Clinical Neuroimmunology and Neuroscience Basel (RC2NB),P. Benkert Department of Clinical Research, University Hospital and University of Basel, Basel, Switzerland J. Kuhle 1. Department of Neurology, University Hospital Basel, Basel, Switzerland. 2. Department of Clinical Research, University Hospital and University of Basel, Basel, Switzerland 3. Research Center for Clinical Neuroimmunology and Neuroscience Basel (RC2NB), A. Papadopoulou 1. Department of Neurology, University Hospital Basel, Basel, Switzerland; 2. De-partment of Clinical Research, University Hospital and University of Basel, Basel, Switzerland; 3. Research Center for Clinical Neuroimmunology and Neuroscience Basel (RC2NB)
|
P02
|
Female sex is associated with higher risk of experiencing a relapse after Fingolimod cessation
Poster flash presentation & ePoster
Neuroinflammatory / -infectious diseases
M. Massy
Speaker
Department of Neurology, Inselspital, Bern University Hospital and University of Bern, SwitzerlandS. Marti Department of Neurology, Inselspital, Bern University Hospital, SwitzerlandM. Pistor Department of Neurology, Inselspital, Bern University Hospital, SwitzerlandA. Chan Department of Neurology, Inselspital, Bern University Hospital, SwitzerlandR. Hoepner Department of Neurology, Inselspital, Bern University Hospital, Switzerland
|
P03
|
Identification of three multiple sclerosis endophenotypes by high dimensional blood signatures associated with distinct disease trajectories
Poster flash presentation & ePoster
Neuroinflammatory / -infectious diseases
C. Gross Department of Neurology with Institute of Translational Neurology, University Hospital of Münster, University of MünsterA. Schulte-Mecklenbeck Department of Neurology with Institute of Translational Neurology, University Hospital of Münster, University of MünsterO. Steinberg Department of Neurology with Institute of Translational Neurology, University Hospital of Münster, University of MünsterT. Wirth Department of Neurology with Institute of Translational Neurology, University Hospital of Münster, University of MünsterS. Lauks Department of Neurology with Institute of Translational Neurology, University Hospital of Münster, University of MünsterS. Bittner Department of Neurology, Focus Program Translational Neuroscience (FTN) and Immunotherapy (FZI), Rhine Main Neuroscience Network (rmn2), University Medical Center of the Johannes Gutenberg University MainzP. Schindler Experimental and Clinical Research Center, a Cooperation between the Max Delbrück Center for Molecular Medicine in the Helmholtz Association and Charité-Universitätsmedizin BerlinS. Baranzini Department of Neurology, Weill Institute for Neurosciences, University of California San FranciscoS. Groppa Department of Neurology, Focus Program Translational Neuroscience (FTN) and Immunotherapy (FZI), Rhine Main Neuroscience Network (rmn2), University Medical Center of the Johannes Gutenberg University MainzJ. Bellmann-Strobl Experimental and Clinical Research Center, a Cooperation between the Max Delbrück Center for Molecular Medicine in the Helmholtz Association and Charité-Universitätsmedizin BerlinN. Bünger Department of Neurology with Institute of Translational Neurology, University Hospital of Münster, University of MünsterC. Chien Experimental and Clinical Research Center, a Cooperation between the Max Delbrück Center for Molecular Medicine in the Helmholtz Association and Charité-Universitätsmedizin BerlinE. Dawin Affiliations: 1 Department of Neurology with Institute of Translational Neurology, University Hospital of Münster, University of MünsterM. Eveslage Institute of Biostatistics and Clinical Research, University of MünsterV. Fleischer Department of Neurology, Focus Program Translational Neuroscience (FTN) and Immunotherapy (FZI), Rhine Main Neuroscience Network (rmn2), University Medical Center of the Johannes Gutenberg University MainzG. Gonzalez-Escamilla Department of Neurology, Focus Program Translational Neuroscience (FTN) and Immunotherapy (FZI), Rhine Main Neuroscience Network (rmn2), University Medical Center of the Johannes Gutenberg University MainzB. Gisevius Department of Neurology, St. Josef-Hospital, Ruhr-University BochumJ. Haas Department of Neurology, University of HeidelbergM. Kerschensteiner Institute of Clinical Neuroimmunology, University Hospital and Biomedical Center (BMC), Faculty of Medicine, Ludwig Maximilians University of MunichL. Kirstein Department of Neurology with Institute of Translational Neurology, University Hospital of Münster, University of MünsterC. Korsukewitz Department of Neurology with Institute of Translational Neurology, University Hospital of Münster, University of MünsterL. Lohmann Department of Neurology with Institute of Translational Neurology, University Hospital of Münster, University of MünsterJ. Lünemann Department of Neurology with Institute of Translational Neurology, University Hospital of Münster, University of MünsterF. Lüssi Department of Neurology, Focus Program Translational Neuroscience (FTN) and Immunotherapy (FZI), Rhine Main Neuroscience Network (rmn2), University Medical Center of the Johannes Gutenberg University MainzG. Meyer zu Hörste Department of Neurology with Institute of Translational Neurology, University Hospital of Münster, University of MünsterJ. Motte Department of Neurology, St. Josef-Hospital, Ruhr-University BochumT. Ruck Department of Neurology, Medical Faculty, Heinrich-Heine-University DüsseldorfK. Ruprecht Department of Neurology, Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu BerlinN. Schwab Department of Neurology with Institute of Translational Neurology, University Hospital of Münster, University of MünsterF. Steffen Department of Neurology, Focus Program Translational Neuroscience (FTN) and Immunotherapy (FZI), Rhine Main Neuroscience Network (rmn2), University Medical Center of the Johannes Gutenberg University MainzS. Meuth Department of Neurology, Medical Faculty, Heinrich-Heine-University DüsseldorfF. Paul Experimental and Clinical Research Center, a Cooperation between the Max Delbrück Center for Molecular Medicine in the Helmholtz Association and Charité-Universitätsmedizin BerlinB. Wildemann Department of Neurology, University of HeidelbergT. Kümpfel Institute of Clinical Neuroimmunology, University Hospital and Biomedical Center (BMC), Faculty of Medicine, Ludwig Maximilians University of MunichR. Gold Department of Neurology, St. Josef-Hospital, Ruhr-University BochumT. Hahn Institute for Translational Psychiatry, University Hospital of Münster, University of MünsterF. Zipp Department of Neurology, Focus Program Translational Neuroscience (FTN) and Immunotherapy (FZI), Rhine Main Neuroscience Network (rmn2), University Medical Center of the Johannes Gutenberg University MainzL. Klotz Department of Neurology with Institute of Translational Neurology, University Hospital of Münster, University of MünsterH. Wiendl
Speaker
Department of Neurology with Institute of Translational Neurology, University Hospital of Münster, University of Münster
|
P04
|
CoGames: Development of a smartphone-based and gamified monitoring tool to assess cognitive function of patients with Multiple Sclerosis
Poster flash presentation & ePoster
Neuroinflammatory / -infectious diseases
S. Pless
Speaker
Research Center for Clinical Neuroimmunology and Neuroscience (RC2NB) Basel, Universitätsspital Basel und Universität BaselT. Woelfle Research Center for Clinical Neuroimmunology and Neuroscience (RC2NB) Basel, Universitätsspital Basel und Universität BaselA. Wiencierz Departement für kliniche ForschungC. Luque INDIVIÓ. Reyes INDIVIP. Calabrese Neuropsychology and behavioral Neurology Unit, Department of Psychology and Interdisciplinary Platform Psychiatry and Psychology, Division of Molecular and Cognitive Neuroscience, Universität BaselC. Granziera Research Center for Clinical Neuroimmunology and Neuroscience (RC2NB) Basel, Universitätsspital Basel und Universität BaselJ. Lorscheider Research Center for Clinical Neuroimmunology and Neuroscience (RC2NB) Basel, Universitätsspital Basel und Universität BaselL. Kappos Research Center for Clinical Neuroimmunology and Neuroscience (RC2NB) Basel, Universitätsspital Basel und Universität Basel
|
P05
|
Intranasal Delivery of TGFα – A Novel Therapeutic Approach for Lesion Resolution in Multiple Sclerosis?
Poster flash presentation & ePoster
Neuroinflammatory / -infectious diseases
L. Lößlein
Speaker
University Hospital ErlangenM. Linnerbauer University Hospital ErlangenF. Zuber University Hospital ErlangenT. Tsaktanis University Hospital ErlangenO. Vandrey University Hospital ErlangenA. Peter University Hospital ErlangenJ. Winkler University Hospital ErlangenN. Schwingen University Hospital ErlangenE. Neumaier University Hospital ErlangenA. Liesz Department of Neurology, Ludwig Maximilian University (LMU), Munich, Germany and Institute for Stroke and Dementia Research (ISD), University Hospital, LMU Munich, Munich, GermanyF. Quintana Harvard Medical School, Boston, MA, USAV. Rothhammer University Hospital Erlangen
|
P06
|
Pregnancy-management in multiple sclerosis: analysis of the Swiss Multiple Sclerosis Cohort
Poster flash presentation & ePoster
Neuroinflammatory / -infectious diseases
M. Einsiedler
Speaker
University Hospital Basel and University of BaselC. Zecca Neurocenter of Southern SwitzerlandL. Hofer University Hospital Basel and University of BaselP. Janiaud University Hospital Basel and University of BaselL. Hemkens University Hospital Basel and University of BaselC. Axfors University Hospital Basel and University of BaselF. Bedussi Institute of Pharmacological Sciences of Southern SwitzerlandA. Ceschi Neurocenter of Southern SwitzerlandG. Disanto Neurocenter of Southern SwitzerlandJ. Müller University Hospital Basel and University of BaselS. Schaedelin University Hospital Basel and University of BaselA. Maceski University Hospital Basel and University of BaselJ. Oechtering University Hospital Basel and University of BaselR. Hoepner University Hospital Bern (Inselspital) and University of BernC. Granziera University Hospital Basel and University of BaselL. Achtnichts Cantonal Hospital AarauC. Pot University Hospital (CHUV) and University of LausanneR. Du Pasquier University Hospital (CHUV) and University of LausanneP. Lalive University Hospital of Geneva & University of GenevaC. Bridel University Hospital of Geneva & University of GenevaS. Müller Cantonal Hospital St GallenL. Kappos University Hospital Basel and University of BaselC. Gobbi Neurocenter of Southern SwitzerlandT. Derfuss University Hospital Basel and University of BaselP. Benkert University Hospital Basel and University of BaselJ. Kuhle University Hospital Basel and University of BaselÖ. Yaldizli University Hospital Basel and University of Basel
|
P07
|
|
P08
|
|
P09
|
Two cases of concurrent syphilis infection and MOG antibody-associated disease: Causation or coincidence?
Poster flash presentation & ePoster
Neuroinflammatory / -infectious diseases
L. Kulsvehagen
Speaker
Departments of Neurology, Biomedicine and Clinical Research, and Research Center for Clinical Neuroimmunology and Neuroscience Basel (RC2NB), University Hospital Basel and University of Basel, Basel, SwitzerlandT. Woelfle Department of Neurology, Research Center for Clinical Neuroimmunology and Neuroscience Basel (RC2NB), and Department of Biomedical Engineering, University Hospital Basel and University of Basel, Basel, SwitzerlandA. Ayroza Galvão Ribeiro Gomes Departments of Neurology, Biomedicine and Clinical Research, and Research Center for Clinical Neuroimmunology and Neuroscience Basel (RC2NB), University Hospital Basel and University of Basel, Basel, SwitzerlandP. Lipps Departments of Neurology, Biomedicine and Clinical Research, and Research Center for Clinical Neuroimmunology and Neuroscience Basel (RC2NB), University Hospital Basel and University of Basel, Basel, SwitzerlandT. Neziraj Departments of Neurology, Biomedicine and Clinical Research, and Research Center for Clinical Neuroimmunology and Neuroscience Basel (RC2NB), University Hospital Basel and University of Basel, Basel, SwitzerlandJ. Flammer Departments of Neurology, Biomedicine and Clinical Research, and Research Center for Clinical Neuroimmunology and Neuroscience Basel (RC2NB), University Hospital Basel and University of Basel, Basel, SwitzerlandK. Leuzinger Clinical Virology, University Hospital Basel, Basel, SwitzerlandT. Derfuss Departments of Neurology, Biomedicine and Clinical Research, and Research Center for Clinical Neuroimmunology and Neuroscience Basel (RC2NB), University Hospital Basel and University of Basel, Basel, SwitzerlandJ. Kuhle Departments of Neurology, Biomedicine and Clinical Research, and Research Center for Clinical Neuroimmunology and Neuroscience Basel (RC2NB), University Hospital Basel and University of Basel, Basel, SwitzerlandA. Papadopoulou Department of Neurology, Research Center for Clinical Neuroimmunology and Neuroscience Basel (RC2NB), and Translational Imaging in Neurology (ThINk), University Hospital Basel and University of Basel, Basel, SwitzerlandA. Pröbstel Departments of Neurology, Biomedicine and Clinical Research, and Research Center for Clinical Neuroimmunology and Neuroscience Basel (RC2NB), University Hospital Basel and University of Basel, Basel, Switzerland
|
P10
|
Dynamic Reshaping of Lymphocyte Repertoires in Multiple Sclerosis Patients Treated with Alemtuzumab: Insights into Secondary Autoimmunity
Poster flash presentation & ePoster
Neuroinflammatory / -infectious diseases
S. Barman
Speaker
Department of Neurology, Medical Faculty and University Hospital Düsseldorf, Heinrich Heine University Düsseldorf, GermanyT. Ruck Department of Neurology, Medical Faculty and University Hospital Düsseldorf, Heinrich Heine University Düsseldorf, GermanyV. Balz Institute of Transplantation Diagnostics and Cell Therapeutics, Heinrich Heine University Düsseldorf, GermanyA. Scheffler Department of Neurology, University Hospital Essen, GermanyS. Pfeuffer Department of Neurology, University Hospital Giessen, GermanyC. Lehrich Department of Neurology with Institute of Translational Neurology, University Hospital Münster, GermanyH. Wiendl Department of Neurology with Institute of Translational Neurology, University Hospital Münster, GermanyN. Melzer Department of Neurology, Medical Faculty and University Hospital Düsseldorf, Heinrich Heine University Düsseldorf, GermanyS. Meuth Department of Neurology, Medical Faculty and University Hospital Düsseldorf, Heinrich Heine University Düsseldorf, GermanyN. Goebels Department of Neurology, Medical Faculty and University Hospital Düsseldorf, Heinrich Heine University Düsseldorf, Germany
|
P11
|
Current trends in stroke events, mortality and case fatality in Switzerland: an epidemiologic update
Poster flash presentation & ePoster
Neurovascular diseases
M. Hänsel
Speaker
Department of Neurology and Clinical Neuroscience Center, University Hospital Zurich and University of Zurich, SwitzerlandE. Mauch Department of Biostatistics at Epidemiology, Biostatistics and Prevention Institute, University of Zurich, SwitzerlandC. Micheloud Department of Biostatistics at Epidemiology, Biostatistics and Prevention Institute, University of Zurich, SwitzerlandA. Luft Department of Neurology and Clinical Neuroscience Center, University Hospital Zurich and University of Zurich, Switzerland and Cereneo Center for Neurology and Rehabilitation, Weggis, SwitzerlandK. Nedeltchev Department of Neurology and Stroke Center, Cantonal Hospital Aarau, Switzerland and Stroke Research Center Bern, Department of Neurology, Inselspital, Bern University Hospital, University of Bern, SwitzerlandM. Arnold Stroke Research Center Bern, Department of Neurology, Inselspital, Bern University Hospital, University of Bern, SwitzerlandU. Held Department of Biostatistics at Epidemiology, Biostatistics and Prevention Institute, University of Zurich, SwitzerlandS. Wegener Department of Neurology and Clinical Neuroscience Center, University Hospital Zurich and University of Zurich, Switzerland
|
P12
|
Temporal characteristics of diffusion-weighted imaging lesions in the acute and post-acute phase of small vessel disease-related intracerebral haemorrhage
Poster flash presentation & ePoster
Neurovascular diseases
M. Göldlin
Speaker
Inselspital, Bern University Hospital, University of BernR. Küttner Inselspital Bern University Hospital, University of BernB. Drop Inselspital Bern University Hospital, University of BernB. Siepen Inselspital Bern University Hospital, University of BernA. Hakim Inselspital Bern University Hospital, University of BernP. Radojewski Inselspital Bern University Hospital, University of BernA. Polymeris University Hospital BaselE. Carrera Hôpitaux Universitaires de GenèveC. Cereda Cantonal Hospital LuganoS. Wegener University Hospital and University of ZurichL. Bonati Reha Rheinfelden and University of BaselM. Katan University Hospital BaselD. Seiffge Inselspital Bern University Hospital, University of Bern
|
P13
|
|
P14
|
ALDH4A1 BLOOD LEVELS AND ATHEROSCLEROTIC DISEASE AMONG PATIENTS WITH ISCHEMIC STROKE
Poster flash presentation & ePoster
Neurovascular diseases
T. Dittrich Cantonal Hospital St. GallenA. Zietz University Hospital BaselF. Gross Cantonal Hospital St. GallenL. Kriemler Cantonal Hospital SchaffhausenM. Arnold University Hospital and University of ZurichJ. Gawinecka University Hospital of ZurichA. von Eckardstein University Hospital of ZurichM. Katan University Hospital BaselG. De Marchis
Speaker
Cantonal Hospital St. Gallen
|
P15
|
Influence of time from symptom-onset on D-dimer levels in acute ischemic stroke
Poster flash presentation & ePoster
Neurovascular diseases
R. Hacialioglu Department of Neurology, Inselspital, Bern University Hospital, and University of Bern, Bern, SwitzerlandM. Kielkopf
Speaker
Department of Neurology, Inselspital, Bern University Hospital, and University of Bern, Bern, SwitzerlandM. Branca CTU Bern, Department of Clinical Research, University of Bern, Bern, SwitzerlandL. Clénin Department of Neurology, Inselspital, Bern University Hospital, and University of Bern, Bern, SwitzerlandA. Boronylo Department of Neurology, Inselspital, Bern University Hospital, and University of Bern, Bern, SwitzerlandN. Silimon Department of Neurology, Inselspital, Bern University Hospital, and University of Bern, Bern, SwitzerlandM. Göldlin Department of Neurology, Inselspital, Bern University Hospital, and University of Bern, Bern, SwitzerlandA. Scutelnic Department of Neurology, Inselspital, Bern University Hospital, and University of Bern, Bern, SwitzerlandJ. Kaesmacher Institute for Diagnostic and Interventional Neuroradiology, Inselspital, Bern University Hospital, and University of Bern, Bern, SwitzerlandA. Mujanovic Institute for Diagnostic and Interventional Neuroradiology, Inselspital, Bern University Hospital, and University of Bern, Bern, SwitzerlandT. Meinel Department of Neurology, Inselspital, Bern University Hospital, and University of Bern, Bern, SwitzerlandD. Seiffge Department of Neurology, Inselspital, Bern University Hospital, and University of Bern, Bern, SwitzerlandM. Heldner Department of Neurology, Inselspital, Bern University Hospital, and University of Bern, Bern, SwitzerlandA. Liberman Clinical and Translational Neuroscience Unit, Feil Family Brain and Mind Research Institute and Department of Neurology, Weill Cornell Medicine, New York, New York, USAB. Navi Clinical and Translational Neuroscience Unit, Feil Family Brain and Mind Research Institute and Department of Neurology, Weill Cornell Medicine, New York, New York, USAU. Fischer Neurology Department, University Hospital of Basel, University of Basel, Basel, SwitzerlandM. Arnold Department of Neurology, Inselspital, Bern University Hospital, and University of Bern, Bern, SwitzerlandS. Jung Department of Neurology, Inselspital, Bern University Hospital, and University of Bern, Bern, SwitzerlandP. Bücke Department of Neurology, Inselspital, Bern University Hospital, and University of Bern, Bern, SwitzerlandM. Beyeler Department of Neurology, Inselspital, Bern University Hospital, and University of Bern, Bern, Switzerland
|
P16
|
Patients with progression independent of relapse activity show increased white matter degeneration on diffusion tensor imaging maps of major white matter tracts
Poster flash presentation & ePoster
Neurodegenerative diseases / Movement disorders
M. Ocampo-Pineda
Speaker
University Hospital Basel and University of BaselA. Cagol University Hospital Basel and University of BaselP. Benkert University Hospital Basel and University of BaselM. Barakovic University Hospital Basel and University of BaselP. Lu University Hospital Basel and University of BaselJ. Müller University Hospital Basel and University of BaselS. Schaedelin University Hospital Basel and University of BaselM. Weigel University Hospital Basel and University of BaselL. Melie-Garcia University Hospital Basel and University of BaselL. Kappos University Hospital Basel and University of BaselJ. Kuhle University Hospital BaselC. Granziera University Hospital Basel and University of Basel
|
P17
|
|
P18
|
Gut bacteria from a human APOE2 donor induce neuroinflammation and protects against AD pathology in a 3xTg AD mouse model
Poster flash presentation & ePoster
Neurodegenerative diseases / Movement disorders
G. FRISONI
Speaker
M. Marizzoni IRCCS Istituto Centro San Giovanni di Dio FatebenefratelliB. Tournier University of Geneva (UNIGE)C. Chevalier University of Geneva (UNIGE)S. Saleri IRCCS Istituto Centro San Giovanni di Dio FatebenefratelliK. Ceyzériat University of Geneva (UNIGE)A. Paquis HUG - University HospitalA. Lathuilliere HUG - University HospitalP. Millet University of Geneva (UNIGE)R. Meyer PDAGT. Meyer-Heim STZ TriemliA. Monsch Felix Platter-Spital, BaselB. Nadége SZB Biel/BienneO. Rouaud CHUV - Hôpital universitaireJ. Popp PUK Zürich
|
P19
|
Association of Blood Pressure Mean and Variability with Hippocampal Subfield Volumes in Cerebral Amyloid Angiopathy with Mild Cognitive Symptoms
Poster flash presentation & ePoster
Neurodegenerative diseases / Movement disorders
L. Sveikata
Speaker
Geneva University Hospitals (HUG) and University of Geneva (Unige), Massachusetts General Hospital, Harvard Medical SchoolM. Zanon Zotin Massachusetts General Hospital, Harvard Medical SchoolV. Perosa Massachusetts General Hospital, Harvard Medical SchoolD. Schoemaker Massachusetts General Hospital, Harvard Medical SchoolS. Farias Da Guarda Massachusetts General Hospital, Harvard Medical SchoolF. Assal Geneva University Hospital and Faculty of MedicineS. Greenberg Massachusetts General Hospital, Harvard Medical SchoolA. Viswanathan Massachusetts General Hospital, Harvard Medical School
|
P20
|
Does focal remyelination in white matter influence myelin-weighted network properties in patients with Multiple Sclerosis?
Poster flash presentation & ePoster
Neurodegenerative diseases / Movement disorders
A. Wenger
Speaker
Translational Imaging in Neurology (ThINK) Basel, Department of Biomedical Engineering, Faculty of Medicine, University Hospital Basel and University of Basel, Basel, SwitzerlandS. Bosticardo Diffusion Imaging and Connectivity Estimation (DICE) Lab, Department of Computer Science, University of Verona, Verona, ItalyM. Weigel Translational Imaging in Neurology (ThINK) Basel, Department of Biomedical Engineering, Faculty of Medicine, University Hospital Basel and University of Basel, Basel, SwitzerlandM. Ocampo-Pineda Translational Imaging in Neurology (ThINK) Basel, Department of Biomedical Engineering, Faculty of Medicine, University Hospital Basel and University of Basel, Basel, SwitzerlandP. Lu Translational Imaging in Neurology (ThINK) Basel, Department of Biomedical Engineering, Faculty of Medicine, University Hospital Basel and University of Basel, Basel, SwitzerlandL. Melie-Garcia Translational Imaging in Neurology (ThINK) Basel, Department of Biomedical Engineering, Faculty of Medicine, University Hospital Basel and University of Basel, Basel, SwitzerlandG. Sanabria Diaz Translational Imaging in Neurology (ThINK) Basel, Department of Biomedical Engineering, Faculty of Medicine, University Hospital Basel and University of Basel, Basel, SwitzerlandA. Cagol Translational Imaging in Neurology (ThINK) Basel, Department of Biomedical Engineering, Faculty of Medicine, University Hospital Basel and University of Basel, Basel, SwitzerlandN. Siebenborn Translational Imaging in Neurology (ThINK) Basel, Department of Biomedical Engineering, Faculty of Medicine, University Hospital Basel and University of Basel, Basel, SwitzerlandE. Ruberte Translational Imaging in Neurology (ThINK) Basel, Department of Biomedical Engineering, Faculty of Medicine, University Hospital Basel and University of Basel, Basel, SwitzerlandP. Calabrese Interdisciplinary Platform, Psychiatry and Psychology, Division of Molecular and Cognitive Neuroscience, Neuropsychology and Behavioral Neurology Unit, University of Basel, Basel, SwitzerlandJ. Kuhle Research Center for Clinical Neuroimmunology and Neuroscience Basel (RC2NB), University Hospital Basel and University of Basel, Basel, SwitzerlandL. Kappos Research Center for Clinical Neuroimmunology and Neuroscience Basel (RC2NB), University Hospital Basel and University of Basel, Basel, SwitzerlandA. Daducci Diffusion Imaging and Connectivity Estimation (DICE) Lab, Department of Computer Science, University of Verona, Verona, ItalyC. Granziera Translational Imaging in Neurology (ThINK) Basel, Department of Biomedical Engineering, Faculty of Medicine, University Hospital Basel and University of Basel, Basel, Switzerland
|
P21
|
|
P22
|
Vestibular perceptual thresholds in patients with Persistent postural perceptual dizziness (PPPD)
Poster flash presentation & ePoster
Others
F. Honegger University Hospital Basel, Basel, SwitzerlandJ. Allum University Hospital Basel, Basel, SwitzerlandK. Roushan Neurootologist in Private Practice, Liestal, CHC. Stieger University Hospital Basel, Basel, SwitzerlandB. Seemungal Imperial College LondonH. Rust
Speaker
University Hospital Basel, Basel, Switzerland
|
P23
|
Antiseizure Medication effects on EEG microstates
Poster flash presentation & ePoster
Epilepsy / Sleep
C. Catania
Speaker
HUG Hôpitaux Universitaires Genève et Université de Genève - faculté de médecineS. Gallotto HUG Hôpitaux Universitaires Genève et Université de Genève - faculté de médecineE. Ménétré HUG Hôpitaux Universitaires Genève et Université de Genève - faculté de médecineM. Seeck HUG Hôpitaux Universitaires Genève et Université de Genève - faculté de médecine
|
P24
|
|
P25
|
Three heterozygous GAA cases mimicking late-onset Pompe disease
Poster flash presentation & ePoster
Neuromuscular diseases
M. Mroczek
Speaker
Center for Cardiovascular Genetics and Gene Diagnostics, Swiss Foundation for People with Rare DiseasesL. Mensova Motol University, Neuromuscular CentreJ. Meienberg Center for Cardiovascular Genetics and Gene Diagnostics, Swiss Foundation for People with Rare DiseasesP. Rejmer Seegarten Klinik AGO. Parmova University Hospital Brno, Department of NeurologyC. Henggeler Center for Cardiovascular Genetics and Gene Diagnostics, Swiss Foundation for People with Rare DiseasesG. Matyas Center for Cardiovascular Genetics and Gene Diagnostics, Swiss Foundation for People with Rare Diseases
|
P26
|
|
P27
|
Real-World Data on Efgartigimod and C5 Complement Inhibition Therapies in Myasthenia gravis
Poster flash presentation & ePoster
Neuromuscular diseases
N. Huntemann
Speaker
Department of Neurology, Medical Faculty and University Hospital Düsseldorf, Heinrich Heine University DüsseldorfC. Nelke Department of Neurology, Medical Faculty and University Hospital Düsseldorf, Heinrich Heine University DüsseldorfC. Schroeter Department of Neurology, Medical Faculty and University Hospital Düsseldorf, Heinrich Heine University DüsseldorfM. Korsen Department of Neurology, Medical Faculty and University Hospital Düsseldorf, Heinrich Heine University DüsseldorfM. Pawlitzki Department of Neurology, Medical Faculty and University Hospital Düsseldorf, Heinrich Heine University DüsseldorfS. Meuth Department of Neurology, Medical Faculty and University Hospital Düsseldorf, Heinrich Heine University DüsseldorfT. Ruck Department of Neurology, Medical Faculty and University Hospital Düsseldorf, Heinrich Heine University Düsseldorf
|
P28
|
|
P29
|
iSPHYNCS: A Multi-Omics Approach Towards Novel Biomarkers for Narcolepsy and its Borderland
Poster flash presentation & ePoster
Epilepsy / Sleep
K. Zub
Speaker
University Hospital Bern (Inselspital), University of BernJ. Warncke University Hospital Bern (Inselspital), University of BernE. Wenz University Hospital Bern (Inselspital), University of BernL. Fregolente University Hospital Bern (Inselspital), University of BernJ. van der Meer University Hospital Bern (Inselspital), University of BernO. Gnarra University Hospital Bern (Inselspital), University of BernR. Morand University Hospital Bern (Inselspital), University of BernA. Helmy University Hospital Bern (Inselspital), University of BernZ. Zhang Clinic Barmelweid, Center for Sleep Medicine and Sleep ResearchR. Khatami Clinic Barmelweid, Center for Sleep Medicine and Sleep ResearchS. von Manitius Kantonsspital St. GallenS. Miano Neurocenter of Southern Switzerland, Regional Hospital (EOC) of LuganoJ. Acker ZurzachCare, Clinic for Sleep MedicineM. Strub Centre for Sleep Medicine BaselM. Tafti University of LausanneA. Datta University Children’s Hospital BaselS. Bürki University Children’s Hospital BaselR. Rezaei University Witten/HerdeckeU. Kallweit University Witten/HerdeckeD. Bijlenga Sleep Wake Centre SEINJ. de Boer Sleep Wake Centre SEING. Lammers Leiden University Medical CentreB. Yilmaz University Hospital Bern (Inselspital), University of BernC. Largiadèr University Hospital Bern (Inselspital), University of BernS. Mougiakakou ETH ZurichA. Tzovara University Hospital Bern (Inselspital), University of BernM. Schmidt University Hospital Bern (Inselspital), University of BernC. Bassetti University Hospital Bern (Inselspital), University of Bern
|
P30
|
Transfer Learning for Automatic Detection of Hypothalamic Hamartomas
Poster flash presentation & ePoster
Epilepsy / Sleep
H. Huppertz
Speaker
Swiss Epilepsy Clinic, Klinik LenggT. Rüber University of Bonn Medical CenterL. Walger University of Bonn Medical CenterL. Imbach Swiss Epilepsy Clinic, Klinik LenggH. Urbach University of Freiburg Medical CenterT. Demerath University of Freiburg Medical Center
|
P31
|
Paramagnetic Rim Lesions are Associated With Enhanced Microstructural Damage and Diffuse Neurodegeneration in People With Multiple Sclerosis
ePoster only
Neuroinflammatory / -infectious diseases
A. Cagol
Speaker
University of BaselM. Ocampo-Pineda University of BaselP. Benkert University of BaselB. Aycı Istanbul University Cerrahpasa Hosp.P. Lu University of BaselL. Melie-Garcia University of BaselS. Schaedelin University of BaselM. Weigel University of BaselS. Leber University of BaselR. Galbusera University of BaselE. Ruberte University of BaselX. Chen University of BaselM. Barakovic University of BaselÖ. Yaldizli University of BaselJ. Oechtering Univerisitätsspital BaselJ. Lorscheider Univerisitätsspital BaselM. D'Souza Univerisitätsspital BaselB. Fischer-Barnicol Univerisitätsspital BaselS. Müller Kantonspital St GallenL. Achtnichts Kantonspital AarauJ. Vehoff Kantonspital St GallenG. Disanto Neurocenter of Southern SwitzerlandO. Findling Kantonspital AarauA. Chan Inselspital - Universitätsspital BernC. Pot CHUV - Hôpital universitaireC. Bridel Geneva University HospitalC. Zecca Neurocenter of Southern SwitzerlandT. Derfuss Univerisitätsspital BaselJ. Lieb Univerisitätsspital BaselL. Remonda Kanontsspital AarauM. Vargas Geneva University HospitalF. Wagner Inselspital - Universitätsspital BernR. Du Pasquier CHUV - Hôpital universitaireP. Lalive Geneva University HospitalE. Pravatà Università della Svizzera ItalianaJ. Weber Clinic Hirslanden ZurichP. Cattin University of BaselR. Hoepner Inselspital - Universitätsspital BernP. Roth Universitätsspital Zurich, University of ZurichC. Gobbi Neurocenter of Southern SwitzerlandD. Leppert University of BaselA. Lutti CHUV - Hôpital universitaireT. Nguyen Weill Cornell MedicineY. Wang Weill Cornell MedicineJ. Lee Seoul National UniversityJ. Kuhle Univerisitätsspital Basel L. Kappos University of BaselM. Sormani Università di GenovaC. Granziera University of Basel
|
P32
|
|
P33
|
Modelling Brain Aging Effect in Multiple Sclerosis: A Multi-Parameter Quantitative MRI Study
ePoster only
Neuroinflammatory / -infectious diseases
X. Chen
Speaker
Translational Imaging in Neurology (ThINK) Basel, Department of Biomedical Engineering, Faculty of Medicine, University Hospital Basel and University of Basel, Basel, SwitzerlandP. Lu Translational Imaging in Neurology (ThINK) Basel, Department of Biomedical Engineering, Faculty of Medicine, University Hospital Basel and University of Basel, Basel, SwitzerlandM. Ocampo-Pineda Translational Imaging in Neurology (ThINK) Basel, Department of Biomedical Engineering, Faculty of Medicine, University Hospital Basel and University of Basel, Basel, SwitzerlandA. Cagol Translational Imaging in Neurology (ThINK) Basel, Department of Biomedical Engineering, Faculty of Medicine, University Hospital Basel and University of Basel, Basel, SwitzerlandL. Rrustemi Translational Imaging in Neurology (ThINK) Basel, Department of Biomedical Engineering, Faculty of Medicine, University Hospital Basel and University of Basel, Basel, SwitzerlandM. Weigel Translational Imaging in Neurology (ThINK) Basel, Department of Biomedical Engineering, Faculty of Medicine, University Hospital Basel and University of Basel, Basel, SwitzerlandS. Schaedelin Translational Imaging in Neurology (ThINK) Basel, Department of Biomedical Engineering, Faculty of Medicine, University Hospital Basel and University of Basel, Basel, SwitzerlandM. Barakovic Translational Imaging in Neurology (ThINK) Basel, Department of Biomedical Engineering, Faculty of Medicine, University Hospital Basel and University of Basel, Basel, SwitzerlandE. Ruberte Translational Imaging in Neurology (ThINK) Basel, Department of Biomedical Engineering, Faculty of Medicine, University Hospital Basel and University of Basel, Basel, SwitzerlandJ. Kuhle Department of Neurology, University Hospital Basel, Basel, SwitzerlandL. Kappos Department of Neurology, University Hospital Basel, Basel, SwitzerlandJ. Marques Donders Centre for Cognitive Neuroimaging, Radboud University, Nijmegen, NetherlandsL. Melie-Garcia Translational Imaging in Neurology (ThINK) Basel, Department of Biomedical Engineering, Faculty of Medicine, University Hospital Basel and University of Basel, Basel, SwitzerlandC. Granziera Translational Imaging in Neurology (ThINK) Basel, Department of Biomedical Engineering, Faculty of Medicine, University Hospital Basel and University of Basel, Basel, Switzerland
|
P34
|
|
P35
|
Dura fibroblasts are heterogeneous and respond with fibrosis to chronic multiple sclerosis
ePoster only
Neuroinflammatory / -infectious diseases
A. Börsch
Speaker
University Hospital Münster, GermanyD. Schafflick University Hospital Münster, GermanyI. Lu University Hospital Münster, GermanyM. Häring University Hospital Münster, GermanyC. Thomas University Hospital Münster, GermanyH. Wiendl University Hospital Münster, GermanyG. Meyer zu Hörste University Hospital Münster, Germany
|
P36
|
|
P37
|
Role of astrocyte metabolism during acute and chronic neuroinflammation
ePoster only
Neuroinflammatory / -infectious diseases
O. Vandrey
Speaker
Department of Neurology, University Hospital, Erlangen, GermanyM. Linnerbauer Department of Neurology, University Hospital, Erlangen, GermanyL. Lößlein Department of Neurology, University Hospital, Erlangen, GermanyA. Peter Department of Neurology, University Hospital, Erlangen, GermanyV. Rothhammer Department of Neurology, University Hospital, Erlangen, Germany
|
P38
|
Immunoregulatory properties of MIF in the context of autoimmune CNS inflammation
ePoster only
Neuroinflammatory / -infectious diseases
A. Peter
Speaker
Friedrich-Alexander-Universität Erlangen-NürnbergM. Linnerbauer Friedrich-Alexander-Universität Erlangen-NürnbergL. Lößlein Friedrich-Alexander-Universität Erlangen-NürnbergO. Vandrey Friedrich-Alexander-Universität Erlangen-NürnbergV. Rothhammer Friedrich-Alexander-Universität Erlangen-Nürnberg
|
P39
|
Escalating to Medium- vs. High-Efficacy Disease Modifying Therapy after Low-Efficacy Treatment in Relapsing Remitting Multiple Sclerosis
ePoster only
Neuroinflammatory / -infectious diseases
J. Müller Neurology Clinic and Policlinic, Departments of Head, Spine and Neuromedicine, MS Center and Translational Imaging in Neurology (ThINk) Basel, Department of Biomedical Engineering, University Hospital Basel and University of BaselI. Roos CORe, Department of Medicine, University of MelbourneT. Kalincik CORe, Department of Medicine, University of MelbourneJ. Lorscheider Neurology Clinic and Policlinic, Departments of Head, Spine and Neuromedicine, MS Center and Translational Imaging in Neurology (ThINk) Basel, Department of Biomedical Engineering, University Hospital Basel and University of BaselG. Edoardo Neurology Clinic and Policlinic, Departments of Head, Spine and Neuromedicine, MS Center and Translational Imaging in Neurology (ThINk) Basel, Department of Biomedical Engineering, University Hospital Basel and University of BaselP. Benkert Department of Clinical Research, Clinical Trial Unit, University Hospital BaselS. Schaedelin Department of Clinical Research, Clinical Trial Unit, University Hospital BaselS. Sharmin CORe, Department of Medicine, University of MelbourneM. Einsiedler Neurology Clinic and Policlinic, Departments of Head, Spine and Neuromedicine, MS Center and Translational Imaging in Neurology (ThINk) Basel, Department of Biomedical Engineering, University Hospital Basel and University of BaselP. Hänni Swiss Federation for Common Tasks of Health Insurances (SVK)J. Schmid Swiss Federation for Common Tasks of Health Insurances (SVK)J. Kuhle Neurology Clinic and Policlinic, Departments of Head, Spine and Neuromedicine, MS Center and Translational Imaging in Neurology (ThINk) Basel, Department of Biomedical Engineering, University Hospital Basel and University of BaselT. Derfuss Neurology Clinic and Policlinic, Departments of Head, Spine and Neuromedicine, MS Center and Translational Imaging in Neurology (ThINk) Basel, Department of Biomedical Engineering, University Hospital Basel and University of BaselC. Granziera Neurology Clinic and Policlinic, Departments of Head, Spine and Neuromedicine, MS Center and Translational Imaging in Neurology (ThINk) Basel, Department of Biomedical Engineering, University Hospital Basel and University of BaselT. Ziemssen Division of Health Care Sciences, Dresden International UniversityT. Siepmann Division of Health Care Sciences, Dresden International UniversityÖ. Yaldizli
Speaker
Neurology Clinic and Policlinic, Departments of Head, Spine and Neuromedicine, MS Center and Translational Imaging in Neurology (ThINk) Basel, Department of Biomedical Engineering, University Hospital Basel and University of Basel
|
P40
|
Predicting Remyelinated Multiple Sclerosis Lesions using Deep Learning
ePoster only
Neuroinflammatory / -infectious diseases
P. Lu
Speaker
University of BaselT. Jayakumar University of BaselE. Ruberte University of BaselN. De Oliveira S. Siebenborn University of BaselA. Cagol University of BaselX. Chen University of BaselM. Ocampo-Pineda University of BaselM. Weigel University of BaselL. Melie-Garcia University of BaselJ. Kuhle University Hospital BaselL. Kappos University Hospital BaselC. Granziera University of Basel
|
P41
|
Safety and Efficacy of Frexalimab in Relapsing Multiple Sclerosis: 48-Week Results from the Phase 2 Open-Label Extension
ePoster only
Neuroinflammatory / -infectious diseases
G. Giovannoni Queen Mary University of London, London, United KingdomC. Granziera
Speaker
Translational Imaging in Neurology (ThINk), Department of Biomedical Engineering, Faculty of Medicine; Research Center for Clinical Neuroimmunology and Neuroscience Basel (RC2NB), University Hospital Basel and University of Basel, Basel, SwitzerlandY. Mao-Draayer Multiple Sclerosis Center of Excellence, Autoimmunity Center of Excellence, Oklahoma Medical Research Foundation, Oklahoma City, OK, United StatesG. Cutter Department of Biostatistics, UAB School of Public Health, Birmingham, AL, United StatesO. Kalbus Department of Neurology, Dnipro State Medical University, Dnipro, UkraineI. Staikov Clinic of Neurology and Sleep Medicine, Acibadem City Clinic University Hospital Tokuda, Sofia, BulgariaM. Dufek 1st Department of Neurology, St. Anne’s University Hospital, Brno, Czech RepublicS. Saubadu Sanofi, Chilly-Mazarin, FranceR. Bejuit Sanofi, Chilly-Mazarin, FranceB. Djukic Sanofi, Cambridge, MA, United StatesP. Truffinet Sanofi, Chilly-Mazarin, FranceE. Wallstroem Sanofi, Cambridge, MA, United StatesP. Vermersch Univ. Lille, Inserm U1172 LilNCog, CHU Lille, FHU Precise, Lille, France
|
P42
|
|
P43
|
Recurrent meningoencephalitis in a T cell dysregulated patient - a case report
ePoster only
Neuroinflammatory / -infectious diseases
R. Pretzsch
Speaker
Department of Neurology, University Hospital Basel, Switzerland, Departments of Biomedicine and Clinical Research, University of Basel, Switzerland, Research Center for Clinical Neuroimmunology and Neuroscience Basel (RC2NB), Basel, SwitzerlandA. Jauslin Department of Neurology, University Hospital Basel, Switzerland M. Mehling Department of Neurology, University Hospital Basel, Switzerland, Departments of Biomedicine and Clinical Research, University of Basel, Switzerland, Research Center for Clinical Neuroimmunology and Neuroscience Basel (RC2NB), Basel, SwitzerlandM. Beer Friedrich-Loeffler-Instut, Institute of Diagnostic Virology, Greifswald, GermanyS. Rueegg Department of Neurology, University Hospital Basel, Switzerland A. Pröbstel Department of Neurology, University Hospital Basel, Switzerland, Departments of Biomedicine and Clinical Research, University of Basel, Switzerland, Research Center for Clinical Neuroimmunology and Neuroscience Basel (RC2NB), Basel, SwitzerlandM. Recher Immunodeficiency Clinic, Medical Outpatient Unit and Immunodeficiency Lab, Department Biomedicine, University Hospital Basel, SwitzerlandU. Fischer Department of Neurology, University Hospital Basel, Switzerland B. Wagner Department of Neurology, University Hospital Basel, Switzerland
|
P44
|
Steroid-resistant clinical and radiological findings in a patient with progressive rhombencephalitis – a case report
ePoster only
Neuroinflammatory / -infectious diseases
A. Jauslin
Speaker
Department of Neurology, University Hospital Basel, Basel, SwitzerlandR. Chareza Department of Neurology, University Hospital Basel, Basel, SwitzerlandM. Dominik Department of Internal Medicine and Neurology, Cantonal Hospital Schaffhausen, Schaffhausen, SwitzerlandJ. Lieb Division of Neuroradiology, Clinic of Radiology & Nuclear Medicine, University Hospital of Basel, Basel, Switzerland.S. Rüegg Department of Neurology, University Hospital Basel, Basel, SwitzerlandM. Mehling Department of Neurology, Departments of Biomedicine and Clinical Research, Research Center for Clinical Neuroimmunology and Neuroscience Basel (RC2NB), University Hospital Basel and University of Basel, Basel, SwitzerlandU. Fischer Department of Neurology, University Hospital Basel, Basel, SwitzerlandJ. Kuhle Department of Neurology, Departments of Biomedicine and Clinical Research, Research Center for Clinical Neuroimmunology and Neuroscience Basel (RC2NB), University Hospital Basel and University of Basel, Basel, SwitzerlandB. Wagner Department of Neurology, University Hospital Basel, Basel, Switzerland
|
P45
|
Assessment of a deep-learning tool for the detection and segmentation of contrast-enhanced lesions in multiple sclerosis patients.
ePoster only
Neurodegenerative diseases / Movement disorders
M. Greselin
Speaker
University Hospital Basel and University of BaselP. Lu University Hospital Basel and University of BaselL. Melie-Garcia University Hospital Basel and University of BaselR. Galbusera University Hospital Basel and University of BaselA. Cagol University Hospital Basel and University of BaselN. De Oliveira S. Siebenborn University Hospital Basel and University of BaselE. Ruberte University Hospital Basel and University of BaselP. Benkert University Hospital Basel, University of BaselS. Müller Cantonal Hospital St. GallenL. Achtnichts Cantonal Hospital AarauJ. Vehoff Cantonal Hospital St. GallenG. Disanto Neurocenter of Southern Switzerland, O. Findling Cantonal Hospital AarauA. Chan Bern University Hospital and University of BernA. Salmen Bern University Hospital and University of BernC. Pot Lausanne University Hospital (CHUV) and University of Lausanne, Service of NeurologyC. Bridel Geneva University Hospitals and Faculty of MedicineC. Zecca Neurocenter of Southern SwitzerlandT. Derfuss University Hospital Basel and University of BaselJ. M. Lieb University Hospital Basel,University of BaselL. Remonda Cantonal Hospital AarauF. Wagner Bern University Hospital and University of BernM. Gomez Geneva University Hospital and Faculty of MedicineR. Du Pasquier Lausanne University Hospital (CHUV) and University of Lausanne, Service of NeurologyP. Patrice Lalive Geneva University Hospitals and Faculty of MedicineE. Pravata Università della Svizzera ItalianaJ. Weber Cantonal Hospital St. GallenC. Gobbi Neurocenter of Southern SwitzerlandD. Leppert University Hospital Basel and University of BaselL. Kappos University Hospital Basel and University of BaselJ. Kuhle University Hospital Basel and University of BaselC. Granziera University Hospital Basel and University of Basel
|
P46
|
Cerebral amyloid angiopathy differently impacts gray matter microstructure in patients with Lewy bodies dementia and Alzheimer’s disease
ePoster only
Neurodegenerative diseases / Movement disorders
G. Bommarito
Speaker
Department of clinical neurosciences, Lausanne University Hospital and University of Lausanne (CHUV-UNIL)A. Griffa Leenaards Memory Center, Lausanne University Hospital and University of Lausanne (CHUV-UNIL)C. Hall Department of clinical neurosciences, Lausanne University Hospital and University of Lausanne (CHUV-UNIL)Y. Aleman-Gomez Department of Radiology, Lausanne University Hospital and University of Lausanne (CHUV-UNIL)P. Hagmann Department of Radiology, Lausanne University Hospital and University of Lausanne (CHUV-UNIL)G. Allali Leenaards Memory Center, Lausanne University Hospital and University of Lausanne (CHUV-UNIL)
|
P47
|
Definition of Chronic Secondary Pain Associated with Parkinson Disease
ePoster only
Neurodegenerative diseases / Movement disorders
V. Mylius
Speaker
Kliniken ValensS. Perez Lloret Pontificia Universidad Católica ArgentinaD. Ciampi de Andrade Faculty of Medicine, Aalborg UniversityJ. Hunger Klinik ValensR. Gonzenbach Klinik ValensJ. Möller Rehaklinik ZihlschlachtG. Kägi KSSG Kantonsspital St. GallenF. Brugger KSSG Kantonsspital St. Gallen
|
P48
|
|
P49
|
On the choroid plexus volume in Alzheimer's disease: A cross-sectional analysis of the Alzheimer’s Disease Neuroimaging Initiative Cohort
ePoster only
Neurodegenerative diseases / Movement disorders
J. Müller Neurology Clinic and Policlinic, Departments of Head, Spine and Neuromedicine, MS Center and Translational Imaging in Neurology (ThINk) Basel, Department of Biomedical Engineering, University Hospital Basel and University of BaselG. Tan Neurology Clinic and Policlinic, Departments of Head, Spine and Neuromedicine, MS Center and Translational Imaging in Neurology (ThINk) Basel, Department of Biomedical Engineering, University Hospital Basel and University of BaselJ. Lorscheider Neurology Clinic and Policlinic, Departments of Head, Spine and Neuromedicine, MS Center and Translational Imaging in Neurology (ThINk) Basel, Department of Biomedical Engineering, University Hospital Basel and University of BaselJ. Kuhle Neurology Clinic and Policlinic, Departments of Head, Spine and Neuromedicine, MS Center and Translational Imaging in Neurology (ThINk) Basel, Department of Biomedical Engineering, University Hospital Basel and University of BaselT. Derfuss Neurology Clinic and Policlinic, Departments of Head, Spine and Neuromedicine, MS Center and Translational Imaging in Neurology (ThINk) Basel, Department of Biomedical Engineering, University Hospital Basel and University of BaselR. Galbusera Neurology Clinic and Policlinic, Departments of Head, Spine and Neuromedicine, MS Center and Translational Imaging in Neurology (ThINk) Basel, Department of Biomedical Engineering, University Hospital Basel and University of BaselT. Sinnecker Neurology Clinic and Policlinic, Departments of Head, Spine and Neuromedicine, MS Center and Translational Imaging in Neurology (ThINk) Basel, Department of Biomedical Engineering, University Hospital Basel and University of BaselM. Sollberger Neurology Clinic and Policlinic, Departments of Head, Spine and Neuromedicine, MS Center and Translational Imaging in Neurology (ThINk) Basel, Department of Biomedical Engineering, University Hospital Basel and University of BaselL. Melie-Garcia Neurology Clinic and Policlinic, Departments of Head, Spine and Neuromedicine, MS Center and Translational Imaging in Neurology (ThINk) Basel, Department of Biomedical Engineering, University Hospital Basel and University of BaselC. Granziera Neurology Clinic and Policlinic, Departments of Head, Spine and Neuromedicine, MS Center and Translational Imaging in Neurology (ThINk) Basel, Department of Biomedical Engineering, University Hospital Basel and University of BaselÖ. Yaldizli
Speaker
Neurology Clinic and Policlinic, Departments of Head, Spine and Neuromedicine, MS Center and Translational Imaging in Neurology (ThINk) Basel, Department of Biomedical Engineering, University Hospital Basel and University of Basel
|
P50
|
Remyelinating lesions are identified through advanced MRI measures of axon, myelin and extracellular compartment properties in multiple sclerosis
ePoster only
Neurodegenerative diseases / Movement disorders
G. Sanabria Diaz
Speaker
University of Basel, University Hospital BaselA. Cagol University of Basel, University Hospital Basel, University of GenovaP. Lu University of Basel, University Hospital BaselM. Barakovic University of Basel, University Hospital BaselM. Ocampo-Pineda University of Basel, University Hospital BaselX. Chen University of Basel, University Hospital BaselM. Weigel University of Basel, University Hospital BaselE. Ruberte University of Basel, University Hospital Basel, Medical Image Analysis Center (MIAC)N. de Oliveira S. Siebenborn University of Basel, University Hospital Basel, Medical Image Analysis Center (MIAC)R. Galbusera University of Basel, University Hospital BaselS. Schaedelin University of Basel, University Hospital BaselP. Benkert University of Basel, University Hospital BaselJ. Kuhle University of Basel, University Hospital BaselL. Kappos University of Basel, University Hospital BaselL. Melie-Garcia University of Basel, University Hospital BaselC. Granziera University of Basel, University Hospital Basel
|
P51
|
The ATN Classification and CSF-Defined Suspected Non-AD Pathology – a Clinical Correlation Study
ePoster only
Neurodegenerative diseases / Movement disorders
N. Briel
Speaker
Department of Neurology, University Hospital Zurich and University of ZurichS. Schreiner Department of Neurology, University Hospital Zurich and University of ZurichS. Loosli Department of Neurology, University Hospital Zurich and University of ZurichC. Togni Department of Neurology, University Hospital Zurich and University of ZurichM. Carta Department of Neurology, University Hospital Zurich and University of ZurichT. Nicoletti Department of Neuropathology, University Hospital Essen, Essen, GermanyT. Weiss Department of Neurology, University Hospital Zurich and University of ZurichH. Jung Department of Neurology, University Hospital Zurich and University of Zurich
|
P52
|
Prediction of language and verbal fluency in Parkinson’s disease patients undergoing Deep Brain stimulation
ePoster only
Neurodegenerative diseases / Movement disorders
S. Elsas
Speaker
University Hospital Basel, BaselT. Al Tawil University Hospital Basel, BaselU. Gschwandtner University Hospital Basel, BaselS. Hemm School of Life Sciences FHNWM. Jermann School of Life Sciences FHNWE. Taub University Hospital Basel, BaselK. Toloraia University Hospital Basel, BaselD. Vogel School of Life Sciences FHNWP. Fuhr University Hospital Basel, Basel
|
P53
|
|
P54
|
|
P55
|
|
P56
|
Association between lower extremity physical function and physical activity after ischemic stroke: longitudinal findings from the MOBITEC-Stroke project
ePoster only
Neurovascular diseases
C. Jäger University Department of Geriatric Medicine Felix Platter, University of BaselM. Ryan University Department of Geriatric Medicine Felix Platter, University of BaselN. Rommers Department of Clinical Research, University of Basel, University Hospital BaselJ. Schär Klinik HirslandenR. Kressig University Department of Geriatric Medicine Felix Platter, University of BaselA. Schmidt-Trucksaess Division of Sport and Exercise Medicine, Department of Sport, Exercise, and Health, University of BaselS. Engelter University of Basel, Switzerland and Neurology and Neurorehabilitation, University Department of Geriatric Medicine FELIX PLATTER, University of BaselT. Hinrichs Division of Sport and Exercise Medicine, Department of Sport, Exercise, and Health, University of BaselR. Roessler University Department of Geriatric Medicine Felix Platter, University of BaselN. Peters
Speaker
University of Basel, Switzerland and Neurology and Neurorehabilitation, University Department of Geriatric Medicine FELIX PLATTER, University of Basel
|
P57
|
|
P58
|
Auditory reaction time in patients with epilepsy and healthy controls
ePoster only
Epilepsy / Sleep
N. Schwab Swiss Epilepsy Center, Klinik Lengg AGR. Renzel Swiss Epilepsy Center, Klinik Lengg AGP. Faber Swiss Epilepsy Center, Klinik Lengg AGM. Capaul Swiss Epilepsy Center, Klinik Lengg AGL. Imbach Swiss Epilepsy Center, Klinik Lengg AGD. Ledergerber
Speaker
Swiss Epilepsy Center, Klinik Lengg AG
|
P59
|
|
P60
|
|
P61
|
|
P62
|
|
P63
|
EEG network dynamics in photosensitive epilepsy depend on stimulation frequency and photosensitivity type
ePoster only
Epilepsy / Sleep
L. Timar Swiss Epilepsy Center, Klinik LenggS. Deplazes Swiss Epilepsy Center, Klinik LenggJ. Bothmann Swiss Epilepsy Center, Klinik LenggT. Dubcek Swiss Epilepsy Center, Klinik Lengg; 2)Decision Neuroscience Lab, ETH Zurich,D. Ledergerber Swiss Epilepsy Center, Klinik LenggL. Imbach
Speaker
Swiss Epilepsy Center, Klinik Lengg; 3)Neuroscience Center Zurich (ZNZ), University of Zurich and ETH Zurich,
|
P64
|
|
P65
|
|
P66
|
Exploring longitudinal alterations of the Corpus Callosum normal-appearing white matter in Relapsing-Remitting and Progressive Multiple Sclerosis
ePoster only
Others
L. Melie-Garcia
Speaker
University of Basel, University Hospital BaselM. Barakovic University of Basel, University Hospital BaselP. Lu University of Basel, University Hospital BaselA. Cagol University of Basel, University Hospital Basel, University of GenovaM. Ocampo-Pineda University of Basel, University Hospital BaselX. Chen University of Basel, University Hospital BaselR. Galbusera University of Basel, University Hospital BaselG. Sanabria-Diaz University of Basel, University Hospital BaselS. Schaedelin University of Basel, University Hospital BaselE. Ruberte Jiménez Probst University of Basel, University Hospital Basel; Medical Image Analysis Center (MIAC)P. Benkert University of Basel, University Hospital BaselL. Kappos University of Basel, University Hospital BaselJ. Kuhle University Hospital BaselC. Granziera University of Basel, University Hospital Basel
|
P67
|
Disparities in Neuroimaging Access and Time to Diagnosis Among Patients with Unprovoked Seizures and Epilepsy: Implications for Diagnostic Precision
ePoster only
Others
S. Gallotto
Speaker
Department of Clinical Neurosciences, Division of Neurology, Geneva University Hospital and Faculty of Medicine, University of Geneva, Switzerland.E. Ménétré Department of Clinical Neurosciences, Division of Neurology, Geneva University Hospital and Faculty of Medicine, University of Geneva, Switzerland.C. Catania Department of Clinical Neurosciences, Division of Neurology, Geneva University Hospital and Faculty of Medicine, University of Geneva, Switzerland.F. Picard Department of Clinical Neurosciences, Division of Neurology, Geneva University Hospital and Faculty of Medicine, University of Geneva, Switzerland.M. Seeck Department of Clinical Neurosciences, Division of Neurology, Geneva University Hospital and Faculty of Medicine, University of Geneva, Switzerland.
|
P68
|
|
P69
|
|